Publications by authors named "Devron R Shah"

Claim this Profile
T
Tyrosine Kinase Inhibitors and Interstitial Lung Disease: A Disproportionality Analysis Using the European Post-marketing EudraVigilance Database.
Devron R Shah, Simon P Hart, Dominic L Sykes

Drugs Real World Outcomes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology.
Rashmi R Shah, Devron R Shah

Drug Saf· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients.
Devron R Shah, Shamik Dholakia, Rashmi R Shah

Drug Saf· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fresh perspective on comparing the FDA and the CHMP/EMA: approval of antineoplastic tyrosine kinase inhibitors.
Rashmi R Shah, Samantha A Roberts, Devron R Shah

Br J Clin Pharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.
Rashmi R Shah, Joel Morganroth, Devron R Shah

Drug Saf· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy.
Devron R Shah, Rashmi R Shah, Joel Morganroth

Drug Saf· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the comments from Drs Shimazawa and Ikeda.
Rashmi R Shah, Devron R Shah

Br J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval).
Rashmi R Shah, Joel Morganroth, Devron R Shah

Drug Saf· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized medicine: is it a pharmacogenetic mirage?
Rashmi R Shah, Devron R Shah

Br J Clin Pharmacol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis